The U.S. Food and Drug Administration has approved Eli Lilly’s new weight-loss GLP-1 pill, orforglipron, which will be sold as Foundayo. AOL: Local doctors say new study of GLP-1s will bolster efforts to make them more available Local doctors say new study of GLP-1s will bolster efforts to make them more available STAT: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target AOL: FDA asks drugmaker Eli Lilly for more safety information on its new GLP-1 weight loss pill FDA asks drugmaker Eli Lilly for more safety information on its new GLP-1 weight loss pill Updates GLP drugs pricing and access highlight new subscription models, FDA approvals, and tighter regulatory oversight in 2024.

Understanding the Context

Everyday Health on MSN: How the new oral GLP-1 weight loss medications work Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how next-gen “small molecule” drugs may change obesity treatment. Forbes: FDA Approves New GLP-1 Weight Loss Pill—What To Know And How To Get It The U.S. Food and Drug Administration on Wednesday approved a second oral GLP-1 medication, giving adults eligible for weight loss medication another option. The new pill, called Foundayo, is made by ...

Key Insights

FDA Approves New GLP-1 Weight Loss Pill—What To Know And How To Get It Yahoo: FDA Approves Foundayo, New GLP-1 Weight Loss Pill Without Food, Water or Timing Restrictions FDA Approves Foundayo, New GLP-1 Weight Loss Pill Without Food, Water or Timing Restrictions By most measures, the new GLP-1 pills are underwhelming. Earlier this month, the pharmaceutical giant Eli Lilly debuted a weight-loss tablet that is far less effective than its po ... Insider: Meet the new GLP-1 consumer, who spends big on supplements, fitness, and updating their wardrobe Meet the new GLP-1 consumer, who spends big on supplements, fitness, and updating their wardrobe The Daily Beast on MSN: GLP-1 patients report new side effect—and it’s hitting relationships hard Restaurant Business Online: Not all GLP-1 users are dining out or spending less, find new surveys Not all GLP-1 users are dining out or spending less, find new surveys